Based on 18F-FDG microPET imaging, brain glucose uptake was significantly decreased in APP/PS1 mice compared with WT mice (P < 0.01, Fig. 3C, D), and this difference was reversed by LPD treatment (P < 0.01, Fig. 3C, D). This evidence concerns the gene APP and disseminated peritoneal leiomyomatosis.